Skip to main content
logo
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
12.85
-0.16 (-1.23%)
At close: Oct 31, 2025, 4:00 PM EDT
12.90
+0.05 (0.39%)
After-hours: Oct 31, 2025, 7:56 PM EDT

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had revenue of $23.19M in the quarter ending June 30, 2025, with 394.01% growth. This brings the company's revenue in the last twelve months to $177.99M, up 2,990.57% year-over-year. In the year 2024, Monte Rosa Therapeutics had annual revenue of $75.62M.

Revenue (ttm)
$177.99M
Revenue Growth
+2,990.57%
P/S Ratio
5.93
Revenue / Employee
$1,328,254
Employees
134
Market Cap
793.61M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202475.62M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca56.50B
Novartis AG56.37B
Novo Nordisk49.11B
Revenue Rankings

GLUE News

More News